Papers: 10.1371/journal.pone.0197372
https://doi.org/10.1371/journal.pone.0197372
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
Cited by: 44
Author(s): Michael J. Thomenius, Jennifer Totman, Darren M. Harvey, Lorna H. Mitchell, Thomas V. Riera, Kat Cosmopoulos, Alexandra R. Grassian, Christine Klaus, Megan Foley, Elizabeth A. Admirand, Haris Jahić, Christina R. Majer, Tim J. Wigle, Suzanne L. Jacques, Jodi Gureasko, Dorothy Brach, Trupti Lingaraj, Kip A. West, Sherri Smith, Nathalie Rioux, Nigel J. Waters, Cuyue Tang, Alejandra Raimondi, Michael J. Munchhof, James E. Mills, Scott Ribich, Margaret Porter Scott, Kevin W. Kuntz, William P. Janzen, Mikel P. Moyer, J. Joshua Smith, Richard Chesworth, Robert A. Copeland, P.A. Boriack-Sjodin
Published: over 8 years ago